PIZZIGALLO, Eligio
 Distribuzione geografica
Continente #
NA - Nord America 7.523
EU - Europa 4.906
AS - Asia 4.901
SA - Sud America 881
Continente sconosciuto - Info sul continente non disponibili 254
AF - Africa 79
OC - Oceania 7
Totale 18.551
Nazione #
US - Stati Uniti d'America 7.261
SG - Singapore 1.759
CN - Cina 1.450
UA - Ucraina 949
BR - Brasile 698
IE - Irlanda 690
GB - Regno Unito 655
TR - Turchia 613
RU - Federazione Russa 581
VN - Vietnam 493
IT - Italia 468
FR - Francia 430
SE - Svezia 420
DE - Germania 369
FI - Finlandia 197
IN - India 197
BD - Bangladesh 114
CA - Canada 112
AR - Argentina 79
HK - Hong Kong 45
ID - Indonesia 41
MX - Messico 28
IQ - Iraq 27
PL - Polonia 25
CO - Colombia 24
EC - Ecuador 24
ZA - Sudafrica 24
ES - Italia 22
KR - Corea 22
AT - Austria 21
CR - Costa Rica 20
CZ - Repubblica Ceca 20
TT - Trinidad e Tobago 19
JP - Giappone 17
JM - Giamaica 16
PK - Pakistan 16
SV - El Salvador 16
CL - Cile 15
CW - ???statistics.table.value.countryCode.CW??? 15
VE - Venezuela 14
UZ - Uzbekistan 13
BE - Belgio 12
HN - Honduras 12
IL - Israele 12
NL - Olanda 12
PY - Paraguay 12
GT - Guatemala 11
SA - Arabia Saudita 11
TN - Tunisia 11
EU - Europa 10
MA - Marocco 9
MY - Malesia 9
PR - Porto Rico 9
SC - Seychelles 9
JO - Giordania 8
LT - Lituania 8
PE - Perù 8
EG - Egitto 7
NI - Nicaragua 7
GP - Guadalupe 6
GR - Grecia 6
IR - Iran 6
KE - Kenya 6
NP - Nepal 6
PH - Filippine 6
AU - Australia 5
AZ - Azerbaigian 5
CH - Svizzera 5
ET - Etiopia 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
EE - Estonia 4
TH - Thailandia 4
BB - Barbados 3
GE - Georgia 3
KZ - Kazakistan 3
LB - Libano 3
OM - Oman 3
DO - Repubblica Dominicana 2
DZ - Algeria 2
KW - Kuwait 2
NG - Nigeria 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AL - Albania 1
BF - Burkina Faso 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
FJ - Figi 1
GD - Grenada 1
HU - Ungheria 1
KH - Cambogia 1
LK - Sri Lanka 1
LY - Libia 1
MK - Macedonia 1
Totale 18.316
Città #
Singapore 1.292
Jacksonville 1.035
San Jose 845
Dublin 688
Chandler 580
Southend 557
Princeton 351
Izmir 340
Ashburn 333
Dallas 327
Nanjing 321
Council Bluffs 310
Beijing 271
Wilmington 191
Santa Clara 178
Cambridge 171
Ho Chi Minh City 165
Los Angeles 159
Tongling 143
The Dalles 132
Buffalo 119
Nanchang 119
Dearborn 115
Hanoi 111
Moscow 102
Altamura 99
Ann Arbor 76
São Paulo 66
Boardman 63
Woodbridge 59
Kunming 58
Munich 58
New York 57
Shenyang 54
Grevenbroich 52
Columbus 44
Tianjin 42
Hebei 41
Milan 41
Hong Kong 36
Jiaxing 35
Toronto 35
Norwalk 28
Pune 28
Chicago 27
Houston 27
Rome 27
Changsha 26
Hangzhou 25
Haiphong 24
Kimball 24
Brooklyn 23
Chieti 23
Lanzhou 21
Augusta 20
Da Nang 20
Phoenix 20
Seoul 20
Atlanta 19
Denver 19
Brno 18
Rio de Janeiro 18
San Mateo 18
Montreal 17
Orem 17
Tokyo 17
Hefei 16
Helsinki 16
London 15
Willemstad 15
North Bergen 14
Redondo Beach 14
San Francisco 14
San José 14
San Salvador 14
Warsaw 14
Belo Horizonte 13
Biên Hòa 13
Tashkent 13
Andover 12
Boston 12
Curitiba 12
Jinan 12
Johannesburg 12
Nuremberg 12
Turku 12
Vienna 12
Brussels 11
Changchun 11
Manchester 11
Recife 11
Silver Spring 11
Stockholm 11
Brasília 10
Charlotte 10
Chennai 10
Fortaleza 10
Mexico City 10
Miami 10
Mumbai 10
Totale 10.814
Nome #
Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C-virus infection and non-alcoholic fatty liver disease. 195
Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. 192
Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. 184
Caso clinico di endoplastite da Staphylococcus capitis. 183
HPV e displasie della cervice uterina: ricerca dell'HPV-DNA con PCR e correlazioni con l'esame citologico, colposcopico e istobioptico 170
La sindrome di Waterhouse-Friderichsen quale complicanza fatale nel bambino febbrile: descrizione di due casi clinici. 164
Acute urinary retention due to HSV-1: a case report 164
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 160
Metabolic modifications in HIV-infected women 158
Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha 155
Cytomegalovirus infection in heart-transplants recipients, in a central region of Italy 154
Alterations in muscles of CFS patients at morphological. biochemical and molecular level. 152
Chronic fatigue syndrome: circadian rhythm and hypothalamic-pituitary-adrenal (HPA) axis impairment. 151
Autoimmunità nelle epatiti croniche in terapia con IFN-alfa 149
Efficacia clinica del trattamento intravescicale con BCG per neoplasie vescicali superficiali in rapporto alla risposta immunitaria indotta. 147
Cystatin C, adipokines and cardiovascular risk in HIV infected patients. 147
Ricerca con PCR e genotipizzazione dell'HPVDNA in donne con dispiasia della cervice uterina e nei loro partner 146
Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy. 146
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 146
Could S-100b be a marker of the neurologic involvement in HIV-affected patients? 143
Valutazione della sindrome da fatica cronica mediante A.B.R.: risultati preliminari 141
Insights the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients 140
Ricerche sull'autoimmunità in alcune epatopatie. 139
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 138
Quality of life, depression and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy. 135
Economic evaluation on HIV treatments: The I.Co.N.A. cohort study. 135
Clinical and Pathogenetical Characterization of 238 Patients of a Chronic Fatigue Syndrome Italian Center 133
Treatment with silibyn- Vitamin E- Phospholipid complex in patients with Hepatitis C infection. 133
Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response. 132
Viral interference between hepatitis B, C and D viruses in dual and triple infections in HIV-positive patients. 131
Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome. 131
Neurite acistica bilaterale HIV-correlata: descrizione di un caso ad evoluzione favorevole in seguito a terapia antiretrovirale. 130
Psychiatric diagnosis and comorbidity and chronic fatigue syndrome 130
Interruption of highly active antiretroviral therpy in HIV clinical practice. 130
Usefulness of Leifson staining method in diagnosis of Helicobacter pylori infection. 130
Acquired immunodeficiency without HIV infection: epidemiology and clinical autcome in Italy. 129
Is moderate HIV-viremia associated with a higher risk of clinical progression in HIV-infected people treated with high active antiretroviral therapy. 129
A leukemic patient with hepatosplenic abscesses due to coagulase-negative staphylococci. 128
Interleukin-4 and interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapy. 128
I potenziali evocati uditivi troncoencefalici nella valutazione della Sindrome da Fatica Cronica. 128
Inguinal lymphadenopathy due to Bartonella henselae 127
Ricerca degli anticorpi fissanti il complemento contro il virus dell'herpes simplex (ed altri virus neurotropi) in pazienti con sclerosi multipla. 126
Effetti del trattamento con vitamina e sulla sintomatologia muscoloscheletrica soggettiva ed oggettiva della sindrome da fatica cronica 125
Hepatitis C virus infection and myositis: a virus localization study. 124
Nuovi aspetti della terapia antibiotica associata (rassegna critica e contributo personale). 124
Vertical transmission of hepatitis C virus: an epidemiological study on 2,980 pregnant women in Italy. 124
The association of chronic hepatitis B and myopathy 123
Proteinuria in an African HIV-infected patient: effects of telmisartan. 123
Peripheral blood mononuclear cell beta-endorphin concentration is decreased in chronic fatigue syndrome and fibromyalgia but not in depression: preliminary report 123
Sensory characterization of somatic parietal tissues in humans with chronic fatigue syndrome 121
Methicillin-resistant staphylococcus epidermidis (MRSE) endocarditis treated with linezolid 121
Short communication: Proangiogenic hematopoietic cells in acute HIV infection 121
High dose of erythropoietin in management of interferon/ribavirin induced anemia 120
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors. 120
L'immunità cellulare nelle epatopatie: stimolazione in vitro dei linfociti con antigeni epatici. 120
Epatite virale B e polimiosite. Descrizione di un caso di polimiosite associato ad epatite virale B. 119
Circadian variations of prolactine (PRL), thyreotropic hormone (TSH), adrenocorticotropic hormone (ACTH) and cortisol (CS) in the chronic fatigue syndrome (CFS). 118
Antibodies to hepatitis A virus in Italian patients with chronic liver disease 116
Metabolic syndrome and cardiovascular risk in HIV-infected patients with lipodystrophy. 116
MR imaging in the clinical diagnosis of chronic fatigue syndrome (CFS). 116
Predictability of sustained virological response to pegylate interferon alpha-2b plus ribavirin therapy by week-8 viral response in HIV-positive patients with chronic hepatitis C infection. 115
Mortality from HIV and TB coinfections in higher in Eastern Europe than in Western Europe and Argentina. 115
b-endorphin concentrations are decreased in peripheral blood mononuclear cells of chronic fatigue syndrome patients: comparison with depression. 115
Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy. 115
Ocular manifestations in chronic fatigue syndrome. 115
An unusual complication of brucellosis: hepatic abscess. 114
Multicentre study on the prevalence of symptoms and symptomatic treatment in HIV infection. 113
Ulteriori osservazioni sul sistema HBeAg-HBeAb in corso di epatite ed in portatori di HBsAg. 112
Granulomatous cheilitis in an HIV positive patient on HAART Therapy. 111
Valutazione comparativa delle tecniche di immunodiffusione su agar e counter-elettroforesi nella ricerca dell'antigene Australia. 110
The impact of rufloxacin given as prophylaxis to patients with cancer on their oral and faecal microflora. 109
Psychophysical distress and alexithymic traits in chronic fatigue syndrome with and without comorbid depression 109
Patient-reported and Physician-estimated Adherence to HAART. 109
Use of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV hepatitis. 108
Attualità sulle infezioni batteriche del SNC. 107
Increased production of oncostatin-M by lymphomononuclear cells from HIV-1-infected patients with neuroAIDS. 107
Le associazioni di antibiotici: aspetti clinici. 106
Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing. 105
An Italian study on health-related quality of life and fatigue in patients with chronic fatigue syndrome and patients with chronic HCV virus infection: similarities and differences 105
Study of immune alterations in patients with Chronic Fatigue Syndrome to reach a better nosografic and pathogenetic characterization of subgroups with different etiologies. 104
Antiretroviral therapy in HIV-infected individuals in clinical practice: are the criteria for initiating and choosing the type of drug regimen based only on immunologic and virologic values? 104
Chronic fatigue syndrome following a toxic exposure. 103
Risk of developing specific AIDS-defining illness in patients coinfected with HIV and hepatitis C virus with or without cirrhosis. 102
Research on a new hepatitis B antigen-antibody system: e- anti-e. 101
Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome 100
Ricerca dell'anticorpo contro il virus A (=HAAb) per l'epidemiologia e la diagnosi dell'epatite A. 99
Discontinuation of Secondary Prophylaxis against Pneumocystis carinii Pneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy. 99
A case report of a new inflammatory eye syndrome in an HIV positive patient: the immune restoration uveitis. 99
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. 98
Inflammatory cytokines and S-100b protein in patients with hepatitis C infection and cryoglobulinemias 98
Comparative analysis of two systems for HCV genotyping. 96
Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failures. 96
Relationship between HAART adherence and adipose tissue alterations. 96
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. 96
Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study. 96
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes 95
Chromatographic and electrophoretic studies of immune complexes in non-A, non-B hepatitis. 95
Submaximal aerobic exercise with mechanical vibrations improves the functional status of patients with Chronic Fatigue Sindrome. 94
Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment out come in Italian chronically HCV-infected patients. 94
Significato clinico dell'antigene “e” e dell'anticorpo anti “e” determinati con il metodo radioimmunologico. 94
Totale 12.442
Categoria #
all - tutte 74.495
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.495


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022479 0 0 0 0 47 12 11 68 52 13 85 191
2022/20231.921 206 271 112 187 178 404 136 112 226 18 27 44
2023/2024708 58 27 34 18 33 205 238 19 0 6 5 65
2024/20252.757 216 579 468 33 21 48 7 145 228 138 270 604
2025/20265.167 409 296 691 789 321 293 727 414 463 403 235 126
2026/20271.343 105 308 207 641 82 0 0 0 0 0 0 0
Totale 18.551